Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Sessions to Check Out During the 2018 ACR/ARHP Annual Meeting

From the College  |  September 17, 2018

Sunday, Oct. 21
Sessions begin at 7:45 a.m. on Sunday. Topics of the day include treat to target for rheumatoid arthritis, pediatric rheumatology, clinical trials, chronic musculoskeletal pain and much more.

From 2:30–4 p.m., attendees will have the opportunity to learn about the use of hydroxychloroquine (HCQ) for systemic lupus erythematosus (SLE) patients, during “The Great Debate: Guidelines for SLE: HCQ Dose Should Be No More Than 5 mg/kg in All Patients.” Why attend the 2018 Great Debate? Multiple studies show that HCQ has many benefits in SLE, such as the prevention of disease flares and cardiovascular benefits. HCQ is the only drug shown to prolong survival in lupus. However, recent ophthalmology guidelines point to potential retinal risks of long-term HCQ use.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Many rheumatologists are confused by the guidelines, the screening tests and their interpretation. In this symposium/debate, attendees will increase their understanding of the benefits and risks of HCQ in SLE and the role of the recent guidelines.

Other sessions include:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Meet the Professor: Pulmonary Manifestations of Rheumatic Disease, 7:45–9:15 a.m.;
  • ACR: Sjögren’s Syndrome: Beyond Dryness: A Comprehensive Approach to Diagnosis & Management, 12:30–2 p.m.; and
  • ACR/ARHP: Psychiatry for the Rheumatology Practice, 2:30–4 p.m.

Monday, Oct. 22
Monday includes the ARHP Daltroy Memorial Lecture: “What Matters in Patient-Provider Relationships? Values, Attitudes & Beliefs,” from 7:30–8:30 a.m. This session addresses how history, life experiences and perspectives informed by race, culture, ethnicity and family of origin can play an important role in patient-provider relationships. Adena Batterman, LCSW, and Jillian Rose, LCSW, MPH, will discuss the importance of the clinician’s own self-awareness and understanding of the patient’s experience from a multicultural perspective. They will provide clinical tools and best practices to help providers work from this framework to uncover what matters most to the patient in an effort to optimize clinical outcomes.

Other sessions include:

  • ACR Clinicopathologic Conference: Under the Microscope: The Evolution of a Diagnosis, 7:30–8:30 a.m.;
  • ACR: AFLAR: Out of Africa: Of Rheumatic Diseases: Pattern, Genetics & Advocacy, 8:30–10 a.m.; and
  • ACR/ARHP: Get Smart: Mobile & Wearable Technology in Rheumatology, 9–10 a.m.

Tuesday, Oct 23
Throughout the Annual Meeting, attendees have the opportunity to register for and participate in workshops, which foster hands-on learning. On Tuesday morning from 7:45–9:45 a.m., attendees can participate in workshop designed to address physician burnout and the stresses associated with working in the healthcare system.

During “Mindfulness for the Physician: Techniques & Skills,” participants will learn the basic constructs of mindfulness, research findings supporting mindfulness meditation for health and well-being, and practice several mindfulness meditation exercises. Methods and resources to apply mindfulness to daily life will also be presented and discussed.

Page: 1 2 3 | Single Page
Share: 

Filed under:Conditions Tagged with:2018 ACR/ARHP Annual MeetingACR/ARHP Annual Meeting

Related Articles

    Reading Rheum

    November 1, 2007

    Handpicked Reviews of Contemporary Literature

    Should Hydroxychloroquine Level Testing Be Standard Care in Lupus?

    February 13, 2020

    The Johns Hopkins Lupus Center, Baltimore, has described its experience using hydroxychloroquine (HCQ) levels.1 Forty-four percent of its patients had levels below 500 ng/mL (partial nonadherence); 13% were severely nonadherent (<200 ng/mL). They were shown their results and educated on HCQ adherence. Adherence then improved to 80%; those with lower HCQ levels had higher disease…

    Rheumatologists Debate Hydroxychloroquine Dosing Guidelines for Lupus

    February 18, 2019

    CHICAGO—The correct dosing of hydroxychloroquine (HCQ) for systemic lupus erythematosus (SLE) is a concern of all rheumatologists. Petros Efthimiou, MD, clinical professor of medicine at New York University, New York City, opened the Great Debate of the 2018 ACR/ARHP Annual Meeting by stating, “Today, we will be discussing a critical clinical problem that affects everyone’s…

    New Study Probes Hydroxychloroquine Adherence During Pregnancy

    May 11, 2023

    Hydroxychloroquine (HCQ) is nearly universally recommended for pregnant patients with systemic lupus erythematosus (SLE) to reduce lupus disease activity and adverse outcomes in pregnancy.1-3 Yet despite strong evidence supporting its benefits, HCQ appears underutilized, with several studies suggesting fewer than half of all women with lupus take this medication during pregnancy.4 How accurately these results…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences